rs368593151
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001101426.4(CRPPA):c.802C>T(p.Arg268*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000174 in 1,612,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001101426.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- myopathy caused by variation in CRPPAInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive limb-girdle muscular dystrophy type 2UInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- congenital muscular dystrophy without intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CRPPA | NM_001101426.4 | c.802C>T | p.Arg268* | stop_gained | Exon 5 of 10 | ENST00000407010.7 | NP_001094896.1 | |
| CRPPA | NM_001368197.1 | c.697C>T | p.Arg233* | stop_gained | Exon 4 of 9 | NP_001355126.1 | ||
| CRPPA | NM_001101417.4 | c.652C>T | p.Arg218* | stop_gained | Exon 4 of 9 | NP_001094887.1 | ||
| CRPPA | NR_160656.1 | n.901-23228C>T | intron_variant | Intron 3 of 7 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152122Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000403 AC: 1AN: 247882 AF XY: 0.00000744 show subpopulations
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1459950Hom.: 0 Cov.: 29 AF XY: 0.0000110 AC XY: 8AN XY: 726202 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152122Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74308 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:2
The R268X nonsense variant in the ISPD gene has been reported previously in an individual with muscle-eye-brain disease who had a second variant identified on the opposite ISPD allele (in trans) (Roscioli et al., 2012). The R268X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. -
- -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 Pathogenic:1
- -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7;C5190987:Autosomal recessive limb-girdle muscular dystrophy type 2U Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg268*) in the ISPD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ISPD are known to be pathogenic (PMID: 23288328). This variant is present in population databases (rs368593151, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with muscle eye brain disease (PMID: 22522421). ClinVar contains an entry for this variant (Variation ID: 31568). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at